Chiesi Group Announces Establishment of New Global Rare Diseases Division

NEXT STORY
Drug Discovery Services (Target Selection, Validation, Lead Optimization) Market Report 2020
PREV STORY
Teleflex Announces Fourth Quarter and Full Year 2019 Earnings Conference Call Information
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cascadian Therapeutics Announces Changes to Board of Directors

SEATTLE, March 13, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

Paratek Pharmaceuticals to Report Second Quarter 2018 Financial Results on August 2, 2018

BOSTON, July 23, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Orion Corporation: Organising meeting of the Board of Directors

ORION CORPORATION         STOCK EXCHANGE RELEASE        20 MARCH 2018 at 17.30 P.M. EET                       Orion ...

author_avatar
NASDAQ Market News